Julio A. Vázquez is Research Professor at the Carlos III Health Institute, and he has been the Director of the National Center for Microbiology until July 2019. Currently carries out his research work in the Neisseria, Listeria and Bordetella Unit. He obtained his doctorate in Microbiology in 1988 at the Complutense University from Madrid (Faculty of Biological Sciences), with a postdoctoral training period in Molecular Microbiology at the University of Sussex in England and later obtained the title of Specialist Biologist in Microbiology and Parasitology. He is a member of the Spanish Society for Infectious Diseases and Clinical Microbiology, of the European Society for Clinical Microbiology and Infectious Diseases, and of the European Meningococcal Disease Society, belonging to the working group on isolate characterization and antimicrobial resistance. He has belonged as an expert to the Invasive Bacterial Disease Coordination Group of the European Center for Disease Control (ECDC) of the European Commission and he has been the Spanish Focal Point at ECDC for Microbiology during 4 years. He is part of the Steering Committee of the Global Meningococcal Initiative, an international group of experts that prepares recommendations for the control and prevention of meningococcal disease both globally and regionally.
Dr. Vázquez actively collaborates with PAHO / WHO acting as an external reference for meningococci of the SIREVA network (Latin American Network for laboratory surveillance of pneumococci, meningococci and haemophilus), and having participated on a significant number of occasions as temporary advisor for PAHO / WHO in missions to control outbreaks, intervention measures, etc.
He is co-author of more than 180 articles in journals with an impact index, and he has written several book chapters on meningococcal disease and / or infectious diseases, and is regularly invited as a speaker at national and international conferences on different aspects of meningococcal disease, gonococcal infection, listeria and other microorganisms of its responsibility. He is and has been Principal Investigator of a good number of Research Projects submitted to peer review, both national and international, as well as Principal Investigator of projects financed by the Pharmaceutical Industry.